A MEHOD OF REDUCING MORTALITY AND MORBIDITY ASSOCIATED WITH CRITICAL ILLNESSES

Application 533/KOLNP/2004 published 2006-04-14, filed 2004-08-22
This invention relates to the use of glucagon-like peptide (GLP-1) compounds to reduce the mortality and morbidity associated with critical illnesses wherein a patient is predisposed to or suffers from some type of respiratory distress (FIG. - nil)

Applicant

ELI LILLY AND COMPANY
LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 USA

Inventor

EFFNDIC SUAD JAKUBOWSKI JOSEPHANTHONY

International Info

Classification: A61K
Publication Number: WO 03/028626 A3
Application Date: 2002-09-19

Priority Information

60/326,330 US 2001-10-01